Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells - PubMed (original) (raw)
Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells
Javier O Valenzuela et al. J Immunol. 2005.
Abstract
Clonal expansion of T cells requires cell division and survival during the proliferative phase of the response. Naive murine CD8 T cells responding to Ag and costimulation undergo an abortive response characterized by impaired clonal expansion, failure to develop effector functions, and long-term tolerance. A third signal provided by IL-12 is required for full expansion, activation, and establishment of memory. The enhanced survival, and thus clonal expansion, supported by IL-12 is not due to increased Bcl-2 or Bcl-x(L) expression; both are maximally activated by signals 1 and 2. In contrast, Bcl-3, recently shown to enhance survival when ectopically expressed in T cells, is increased only when IL-12 is present. Furthermore, examination of Bcl-3-deficient CD8 T cells demonstrates that the increased survival caused by IL-12 depends upon Bcl-3. The time courses of expression suggest that Bcl-2 and Bcl-x(L) promote survival early in the response, whereas Bcl-3 acts later in the response.
Similar articles
- CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine.
Curtsinger JM, Johnson CM, Mescher MF. Curtsinger JM, et al. J Immunol. 2003 Nov 15;171(10):5165-71. doi: 10.4049/jimmunol.171.10.5165. J Immunol. 2003. PMID: 14607916 - The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells.
Valenzuela J, Schmidt C, Mescher M. Valenzuela J, et al. J Immunol. 2002 Dec 15;169(12):6842-9. doi: 10.4049/jimmunol.169.12.6842. J Immunol. 2002. PMID: 12471116 - Il-12 enhances CD8 T cell homeostatic expansion.
Kieper WC, Prlic M, Schmidt CS, Mescher MF, Jameson SC. Kieper WC, et al. J Immunol. 2001 May 1;166(9):5515-21. doi: 10.4049/jimmunol.166.9.5515. J Immunol. 2001. PMID: 11313390 - Bcl-x and the regulation of survival in the immune system.
Behrens TW, Mueller DL. Behrens TW, et al. Immunol Res. 1997;16(2):149-60. doi: 10.1007/BF02786359. Immunol Res. 1997. PMID: 9212361 Review. - Inflammatory cytokines as a third signal for T cell activation.
Curtsinger JM, Mescher MF. Curtsinger JM, et al. Curr Opin Immunol. 2010 Jun;22(3):333-40. doi: 10.1016/j.coi.2010.02.013. Epub 2010 Apr 2. Curr Opin Immunol. 2010. PMID: 20363604 Free PMC article. Review.
Cited by
- Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models.
Di Trani CA, Cirella A, Arrizabalaga L, Bella Á, Fernandez-Sendin M, Russo-Cabrera JS, Gomar C, Olivera I, Bolaños E, González-Gomariz J, Álvarez M, Etxeberria I, Palencia B, Teijeira Á, Melero I, Berraondo P, Aranda F. Di Trani CA, et al. Oncoimmunology. 2022 Dec 15;12(1):2147317. doi: 10.1080/2162402X.2022.2147317. eCollection 2023. Oncoimmunology. 2022. PMID: 36531687 Free PMC article. - The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity.
Lukhele S, Rabbo DA, Guo M, Shen J, Elsaesser HJ, Quevedo R, Carew M, Gadalla R, Snell LM, Mahesh L, Ciudad MT, Snow BE, You-Ten A, Haight J, Wakeham A, Ohashi PS, Mak TW, Cui W, McGaha TL, Brooks DG. Lukhele S, et al. Immunity. 2022 Dec 13;55(12):2369-2385.e10. doi: 10.1016/j.immuni.2022.10.020. Epub 2022 Nov 11. Immunity. 2022. PMID: 36370712 Free PMC article. - 2-Methoxy-1,4-naphthoquinone (MNQ) regulates cancer key genes of MAPK, PI3K, and NF-κB pathways in Raji cells.
Wong TY, Menaga S, Huang CF, Ho SHA, Gan SC, Lim YM. Wong TY, et al. Genomics Inform. 2022 Mar;20(1):e7. doi: 10.5808/gi.21041. Epub 2022 Mar 31. Genomics Inform. 2022. PMID: 35399006 Free PMC article. - Cytotoxic T Lymphocyte Activation Signals Modulate Cytoskeletal Dynamics and Mechanical Force Generation.
Pathni A, Özçelikkale A, Rey-Suarez I, Li L, Davis S, Rogers N, Xiao Z, Upadhyaya A. Pathni A, et al. Front Immunol. 2022 Mar 16;13:779888. doi: 10.3389/fimmu.2022.779888. eCollection 2022. Front Immunol. 2022. PMID: 35371019 Free PMC article. - Brief in vitro IL-12 conditioning of CD8 + T Cells for anticancer adoptive T cell therapy.
Salem ML, Salman S, Barnawi IO. Salem ML, et al. Cancer Immunol Immunother. 2021 Oct;70(10):2751-2759. doi: 10.1007/s00262-021-02887-7. Epub 2021 May 8. Cancer Immunol Immunother. 2021. PMID: 33966093 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials